Jianting Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianting Long has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Lixia Xu
The First Affiliated Hospital, Sun Yat-sen University 2 Institute of Precision Medicine Guangzhou, China
30 shared publications - Ming Kuang
Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
30 shared publications - Sui Peng
Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
30 shared publications - Changyi Liao
First Affiliated Hospital of Sun Yat-sen University 1 Guangzhou, Guangdong
15 shared publications - Feng Luo
First Affiliated Hospital of Sun Yat-sen University 1 Guangzhou, Guangdong
15 shared publications - Han Xiao
Department of Medical Ultrasonics, The First Affililated Hospital of Sun Yat-sen University, Guangzhou, P.R. China
15 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Cell Death & Disease
Palmitoylation of Smad2 assists TGFβ-Smad signaling to promote breast cancer metastasis
Although the role of palmitic acid (PA) as a membrane component in promoting cancer invasion and migration has been explored, it remains unclear whether and how PA enhances breast cancer metastasis via palmitoylation modification. Here, we observed that PA promotes epithelial-mesenchymal transition (EMT), invasion, and migration in breast cancer cells, which could be antagonized by the palmitoyl-transferase inhibitor 2-bromopalmitate (2-BP) through regulating TGFβ-Smad pathway. Specifically, we screened and identified that Smad2 undergoes ZDHHC7-mediated palmitoylation, which stabilizes Smad2 protein, enhances Smad2/Smad3 interaction, and promotes their binding to DNA elements following TGFβ stimulation, thereby promoting EMT. Consequently, ZDHHC7 enhanced breast cancer cell migration, and its depletion effectively suppressed breast cancer lung metastasis. Based on these findings, we generated cell-penetrating peptides to block Smad2 palmitoylation, resulting in disrupting its interaction with Smad3, and in turn attenuate breast cancer EMT, invasion, and migration in cells and in orthotopic mouse models. In summary, our study reveals a novel mechanism by which PA promotes breast cancer metastasis through ZDHHC7-mediated palmitoylation of Smad2, and proposes a therapeutic strategy to inhibit breast cancer lung metastasis by using a specific peptide targeting this modification.
- 13 November 2026
- Published by Springer Nature in Cell Death & Disease
Open AccessPalmitoylation of Smad2 assists TGFβ-Smad signaling to promote breast cancer metastasis
Although the role of palmitic acid (PA) as a membrane component in promoting cancer invasion and migration has been explored, it remains unclear whether and how PA enhances breast cancer metastasis via palmitoylation modification. Here, we observed that PA promotes epithelial-mesenchymal transition (EMT), invasion, and migration in breast cancer cells, which could be antagonized by the palmitoyl-transferase inhibitor 2-bromopalmitate (2-BP) through regulating TGFβ-Smad pathway. Specifically, we screened and identified that Smad2 undergoes ZDHHC7-mediated palmitoylation, which stabilizes Smad2 protein, enhances Smad2/Smad3 interaction, and promotes their binding to DNA elements following TGFβ stimulation, thereby promoting EMT. Consequently, ZDHHC7 enhanced breast cancer cell migration, and its depletion effectively suppressed breast cancer lung metastasis. Based on these findings, we generated cell-penetrating peptides to block Smad2 palmitoylation, resulting in disrupting its interaction with Smad3, and in turn attenuate breast cancer EMT, invasion, and migration in cells and in orthotopic mouse models. In summary, our study reveals a novel mechanism by which PA promotes breast cancer metastasis through ZDHHC7-mediated palmitoylation of Smad2, and proposes a therapeutic strategy to inhibit breast cancer lung metastasis by using a specific peptide targeting this modification.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Data from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Neutrophils are major players in innate immunity. However, their landscape and functions in colorectal cancer liver metastasis (CRLM) remain poorly understood. In this study, using single-cell RNA sequencing and spatial-enhanced-resolution-omics sequencing, we provide a comprehensive transcriptional landscape of tumor-associated neutrophils (TAN) in CRLM. Our analysis reveals that a terminally differentiated protumor neutrophil subset (TAN1), characterized by a glycolysis signature and a senescent phenotype, is significantly enriched in liver metastasis and associated with poor prognosis. Mechanistically, TAN1 arises from other TAN subsets through the upregulation of BHLHE40, driven by glucose deprivation in the metastatic microenvironment. Functionally, TAN1 promotes angiogenesis via VEGFA and recruits immunosuppressive macrophages through potential CCL3L1–CCR1 signaling, thereby fostering an angiogenic immunosuppressive niche. As a result, neutrophil-specific knockout of Bhlhe40 in mice significantly promotes antitumor immunity and suppresses tumor growth. Our data uncover the critical role of BHLHE40+ senescent-like neutrophils in shaping the immunosuppressive microenvironment of CRLM. Significance:This study identifies a protumoral BHLHE40+ senescent-like neutrophil subset in CRLM that orchestrates vascular immunosuppressive niches to drive tumor progression, highlighting a potential target for neutrophil-specific therapeutic intervention.See related commentary by Droin and Garner, p. 1958
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Neutrophils are major players in innate immunity. However, their landscape and functions in colorectal cancer liver metastasis (CRLM) remain poorly understood. In this study, using single-cell RNA sequencing and spatial-enhanced-resolution-omics sequencing, we provide a comprehensive transcriptional landscape of tumor-associated neutrophils (TAN) in CRLM. Our analysis reveals that a terminally differentiated protumor neutrophil subset (TAN1), characterized by a glycolysis signature and a senescent phenotype, is significantly enriched in liver metastasis and associated with poor prognosis. Mechanistically, TAN1 arises from other TAN subsets through the upregulation of BHLHE40, driven by glucose deprivation in the metastatic microenvironment. Functionally, TAN1 promotes angiogenesis via VEGFA and recruits immunosuppressive macrophages through potential CCL3L1–CCR1 signaling, thereby fostering an angiogenic immunosuppressive niche. As a result, neutrophil-specific knockout of Bhlhe40 in mice significantly promotes antitumor immunity and suppresses tumor growth. Our data uncover the critical role of BHLHE40+ senescent-like neutrophils in shaping the immunosuppressive microenvironment of CRLM. Significance:This study identifies a protumoral BHLHE40+ senescent-like neutrophil subset in CRLM that orchestrates vascular immunosuppressive niches to drive tumor progression, highlighting a potential target for neutrophil-specific therapeutic intervention.See related commentary by Droin and Garner, p. 1958
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S1. the role of neutrophils in liver metastasis in CRLM mouse models.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S1. the role of neutrophils in liver metastasis in CRLM mouse models.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S2. Single-cell annotation in CRLM.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S2. Single-cell annotation in CRLM.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S5. Single-cell analysis of neutrophil markers in peripheral blood and bone marrow.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S5. Single-cell analysis of neutrophil markers in peripheral blood and bone marrow.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S3. Characterization and tissue distribution of neutrophil subsets in CRC and CRLM from public datasets.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S3. Characterization and tissue distribution of neutrophil subsets in CRC and CRLM from public datasets.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S4. Localization of TAN subsets in liver metastasis.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S4. Localization of TAN subsets in liver metastasis.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S6. Analysis of BHLHE40 binding and hypoxia/glycolysis signature in neutrophils from CRLM.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S6. Analysis of BHLHE40 binding and hypoxia/glycolysis signature in neutrophils from CRLM.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S7. Function of neutrophils and neutrophil-T cell interactions in CRLM.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S7. Function of neutrophils and neutrophil-T cell interactions in CRLM.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S8. Role of neutrophil-specific Bhlhe40 knockout in the liver orthotopic implantation mouse model.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
Figure S8. Role of neutrophil-specific Bhlhe40 knockout in the liver orthotopic implantation mouse model.